chr6-108561428-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001455.4(FOXO3):c.220G>A(p.Gly74Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,538,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001455.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXO3 | NM_001455.4 | c.220G>A | p.Gly74Ser | missense_variant | 1/3 | ENST00000406360.2 | NP_001446.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXO3 | ENST00000406360.2 | c.220G>A | p.Gly74Ser | missense_variant | 1/3 | 1 | NM_001455.4 | ENSP00000385824 | P1 | |
FOXO3 | ENST00000343882.10 | c.220G>A | p.Gly74Ser | missense_variant | 2/4 | 1 | ENSP00000339527 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000332 AC: 5AN: 150816Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000460 AC: 6AN: 130512Hom.: 0 AF XY: 0.0000559 AC XY: 4AN XY: 71618
GnomAD4 exome AF: 0.0000166 AC: 23AN: 1387128Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 16AN XY: 684398
GnomAD4 genome AF: 0.0000331 AC: 5AN: 150918Hom.: 0 Cov.: 33 AF XY: 0.0000407 AC XY: 3AN XY: 73750
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.220G>A (p.G74S) alteration is located in exon 1 (coding exon 1) of the FOXO3 gene. This alteration results from a G to A substitution at nucleotide position 220, causing the glycine (G) at amino acid position 74 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at